| Literature DB >> 28893230 |
Picheswara Rao Polu1, Udupa Nayanbhirama2, Saleemulla Khan1, Rajlexmi Maheswari1.
Abstract
BACKGROUND: Tinospora cordifolia (Guduchi or Amrita) is an important drug of Ayurvedic System of Medicine and found mention in various classical texts for the treatment of diseases such as jaundice, fever, diabetes, cancer and skin disease etc. In view of its traditional claims, antioxidant and anti-proliferative activities were evaluated in the present study.Entities:
Keywords: Anti-oxidant; Berberine; Cervical carcinoma; SRB assay; Tinospora cordifolia
Mesh:
Substances:
Year: 2017 PMID: 28893230 PMCID: PMC5594595 DOI: 10.1186/s12906-017-1953-3
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Fig. 1Schematic representation of extraction and fractionation of T cordifolia
Percent yield, total phenolic and flavonoid content of extract and fractions of T cordifolia
| S.No | Extract/Fraction | Percentage yield (%w/w) | Total phenolic content (mg GAE/g of plant extract) | Total Flavonoid content (mg QE/g of plant extract) |
|---|---|---|---|---|
| 1 | TCE | 7.4 | 4.2 ± 0.25a | 0.52 ± 0.02 a |
| 2 | TCP | 19.08 | 1.1 ± 0.04 b | 0.98 ± 0.01 b |
| 3 | TCD | 17.90 | 2.4 ± 0.39 c | 0.19 ± 0.10 c |
| 4 | TCB | 16.21 | 5.1 ± 0.18 d | 0.25 ± 0.02 d |
| 5 | TCA | 42.56 | 1.8 ± 0.16 e | 0.17 ± 0.08 e |
All the values are expressed as mean ± SEM (n = 3)
a-eColumn wise values with different superscripts of this type indicate significant difference (P < 0.05)
Fig. 2In vitro antioxidant assays of T cordifolia. Antioxidant activities of ethanol extracts and its fractions of T cordifolia. IC50 values were calculated by mean percentage of Scavenging at different concentrations (12.5, 25, 50,100 and 200 μg/mL). a) DPPH assay b) ABTS assay c) FRAP assay d) Nitric oxide assay e) Total antioxidant capacity
Free radical scavenging and antioxidant capacity of extract and fractions of T cordifolia
| Extract/Fraction | DPPH scavenging IC50 (μg/mL) | ABTS scavenging IC50 (μg/mL) | Nitric oxide scavenging IC50 (μg/mL) | Iron chelation IC50 (μg/mL) | Total antioxidant capacityf |
|---|---|---|---|---|---|
| TCE | 16.87 ± 0.08a | 28.24 ± 1.83a | 86.09 ± 0.74a | 29.70 ± 1.08a | 34.46 ± 1.37a |
| TCP | 183.47 ± 2.20b | >1000 | 491.57 ± 1.25b | 54.94 ± 2.97b | 53.27 ± 2.24b |
| TCD | 95.96 ± 0.62c | 132.4 ± 1.14b | 306.25 ± 1.29c | 22.25 ± 0.46a | 34.33 ± 2.27a |
| TCB | 14.18 ± 0.53a | 29.48 ± 2.233a | 58.20 ± 0.70a | 21.17 ± 1.19c | 33.57 ± 1.17a |
| TCA | 74.25 ± 2.14d | 92.46 ± 2.06c | 182.14 ± 1.03d | 46.23 ± 0.34d | 39.92 ± 0.9a |
| Ascorbic acid | 2.57 ± 0.31e | 4.17 ± 0.29d | – | 1.82 ± 0.07e | – |
| Curcumin | – | – | 15.03 ± 0.79e | – | – |
All the values are expressed as mean ± SEM (n = 3)
a-eColumn wise values with different superscripts of this type indicate significant difference (P < 0.05). f-Total antioxidant capacity expressed as μg ascorbic acid equivalents/mg extract
Cytotoxicity results of T cordifolia on HeLa cell line. Cytotoxicity results of T cordifolia by MTT assay on HeLa (Human cervical carcinoma)
| S.No | Concentration (μg/mL) | % Cell Death | |||||
|---|---|---|---|---|---|---|---|
| TCE | TCP | TCD | TCB | TCA | Doxorubicin | ||
| 1 | 0.01 | – | – | – | – | – | 39.81 ± 1.06** |
| 2 | 0.1 | – | – | – | – | – | 48.24 ± 0.27** |
| 3 | 1 | – | – | – | – | – | 68.43 ± 1.02** |
| 4 | 10 | – | – | – | – | – | 82.54 ± 0.92** |
| 5 | 25 | 39.92 ± 0.36* | 29.24 ± 0.64 | 55.02 ± 0.68** | 3.63 ± 1.54 | 13.47 ± 1.88 | – |
| 6 | 50 | 56.06 ± 0.73** | 53.34 ± 0.48** | 55.95 ± 0.43** | 29.79 ± 1.79 | 25.84 ± 1.51 | – |
| 7 | 100 | 66.76 ± 0.51** | 66.00 ± 1.12* | 73.90 ± 0.59** | 40.95 ± 0.69* | 28.58 ± 1.98 | – |
| 8 | 200 | 80.97 ± 1.71** | 77.30 ± 0.33* | 81.60 ± 0.28** | 76.54 ± 0.58* | 84.02 ± 0.46** | – |
| 9 | IC50 | 101.26 ± 1.42b | 131.94 ± 1.23c | 54.23 ± 0.94a | 276.03 ± 2.00 | 366.05 ± 1.74 | 1.89 ± 0.02a |
Results were expressed as Mean ± SEM (n = 3) and analysed using one-way ANOVA followed by Tukey’s post hoc test of significance [where different alphabets denote significant difference (p < 0.05)]. Statistical comparison between the mean % viability of each extract and its negative control was performed using one-way ANOVA followed by Dunnett’s post hoc test of significance wherein *p < 0.05 and **p < 0.01 were considered to be statistically significant and very statistically significant compared to negative control. T cordifolia extracts were tested at concentrations of 200, 100, 50, 25 μg/mL and Doxorubicin was tested at concentrations of 0.01, 0.1, 1 and 10 μg/mL
Cytotoxicity results of T cordifolia on HeLa cell line. Cytotoxicity results of T cordifolia by SRB assay on HeLa (Human cervical carcinoma)
| S.No | Concentration (μg/mL) | % Cell Death | |||||
|---|---|---|---|---|---|---|---|
| TCE | TCP | TCD | TCB | TCA | Doxorubicin | ||
| 1 | 0.01 | – | – | – | – | – | 44.17 ± 0.38** |
| 2 | 0.1 | – | – | – | – | – | 47.40 ± 0.17** |
| 3 | 1 | – | – | – | – | – | 69.53 ± 0.02** |
| 4 | 10 | – | – | – | – | – | 83.45 ± 0.18** |
| 5 | 25 | 44.58 ± 0.19* | 27.04 ± 0.95* | 58.01 ± 0.11** | 4.42 ± 3.68 | 10.64 ± 4.20 | – |
| 6 | 50 | 55.92 ± 0.71* | 49.62 ± 0.35 | 59.46 ± 0.04** | 27.50 ± 0.18 | 19.70 ± 2.62 | – |
| 7 | 100 | 69.84 ± 0.24** | 58.60 ± 0.17* | 76.68 ± 0.21** | 42.10 ± 3.02* | 33.42 ± 4.00 | – |
| 8 | 200 | 82.50 ± 0.83** | 75.47 ± 0.12** | 83.72 ± 0.19** | 68.21 ± 2.45* | 80.02 ± 0.38** | – |
| 9 | IC50 | 87.93 ± 0.85b | 139.54 ± 1.54c | 48.91 ± 0.33a,b | 283.91 ± 2.93 | 377.39 ± 1.09 | 1.85 ± 0.02a |
Results were expressed as Mean ± SEM (n = 3) and analysed using one-way ANOVA followed by Tukey’s post hoc test of significance [where different alphabets denote significant difference (p < 0.05)]. Statistical comparison between the mean % viability of each extract and its negative control was performed using one-way ANOVA followed by Dunnett’s post hoc test of significance wherein *p < 0.05 and **p < 0.01 were considered to be statistically significant and very statistically significant compared to negative control. T cordifolia extracts were tested at concentrations of 200, 100, 50, 25 μg/mL and Doxorubicin was tested at concentrations of 0.01, 0.1, 1 and 10 μg/mL
Fig. 3In vitro MTT and SRB assays on HeLa cells. HeLa cells were incubated with different concentrations (25, 50, 100, 200 μg/mL) of ethanol extract and its fractions of T cordifolia; Growth inhibition was determined by the MTT and SRB assays. IC50 values were calculated by mean percentage of cell death at different concentrations. a) MTT assay and b) SRB assay
Estimation of berberine in T cordifolia extract/fractions by HPTLC
| S.No | Sample | Rf Value | Peak Area | Percentage Content (%w/w) |
|---|---|---|---|---|
| 1 | Berberine | 0.57 | 23,546.6 | 95.24 |
| 2 | Ethanol Extract | 0.57 | 2112.4 | 0.42 |
| 3 | DCM fraction | 0.57 | 5405.1 | 1.09 |
| 4 | n-Butanol fraction | 0.57 | 958.1 | 0.19 |
Fig. 4Estimation of berberine in T cordifolia ethanol extract and its fractions. Representative chromatograms illustrate High Performance Thin Layer Chromatography (HPTLC) of berberine. (a) Standard berberine b) ethanol extract (TCE) (c) Petroleum ether fraction (TCP) (d) Dichloromethane (TCD) fraction e) n-Butanol fraction (TCB) and f) Aqueous fraction (TCA) . Scanned at 350 nm and berberine eluted at Rf value of 0.57